Opportunity Information: Apply for RFA FD 23 018
The Assuring Radiation Protection (U18) Clinical Trial Not Allowed opportunity (RFA-FD-23-018) is a discretionary cooperative agreement funded by the U.S. Food and Drug Administration (FDA), within the Department of Health and Human Services, focused on consumer protection and public health as it relates to radiation safety. The purpose is to support coordinated Federal and State efforts that help ensure the American public is protected from radiation-related risks, particularly in areas tied to FDA's responsibilities for electronic products that emit radiation. This is a renewal-focused announcement, meaning FDA is specifically signaling that it intends to accept and evaluate a renewal application rather than broadly competing multiple brand-new awards.
Funding for the project is approximately $105,000 total for fiscal year 2023, with an expected number of awards of one, and an award ceiling of $105,000. The opportunity uses a cooperative agreement mechanism (U18), which generally means the FDA expects to have substantial involvement in the funded activities compared with a standard grant. In practice, that typically translates to ongoing collaboration, coordination, and shared planning between the recipient and FDA to achieve the program goals. The listing notes "Clinical Trial Not Allowed," indicating the project is not meant to support clinical research or trial activity, and funded work should remain in the realm of coordination, education, committee-based problem solving, and programmatic support tied to radiation protection.
The main work described centers on improving coordination and alignment between Federal and State partners on radiation protection activities. A key deliverable is planning and facilitating an annual meeting that brings relevant stakeholders together to discuss current challenges, share approaches, and promote consistent strategies. In addition, the recipient is expected to develop and offer educational activities that demonstrate practical, mutually beneficial techniques, procedures, and systems that advance the broader mission of assuring radiation protection. These educational efforts are meant to be applied and useful, helping participants adopt better methods or improve existing programs rather than simply exchanging information.
Another major expectation is the establishment of committees to address a wide range of radiation health and protection issues. These committees are intended to identify and evaluate problems, discuss emerging concerns, and propose solutions that can be used by agencies and partners involved in radiation safety. The emphasis is on structured, ongoing forums that can track issues over time and generate actionable recommendations, which supports the broader goal of consistent and effective radiation protection across jurisdictions.
The program is authorized under section 532 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ii). This statutory authority supports FDA's ability to establish and operate an electronic product radiation control program, which is the regulatory foundation for FDA's role in overseeing radiation-emitting electronic products and promoting public safety in that space. In other words, while the award funds coordination and education, it ties back to FDA's legal responsibilities related to radiation-emitting products and the systems needed to manage associated public health risks.
Administrative details included in the notice indicate the opportunity was created on November 29, 2022, with an original closing date of February 14, 2023. Eligibility is listed broadly as "Others," with clarification referenced in the funding notice's eligibility section. Overall, the opportunity is best understood as targeted support for a single recipient to serve a convening and coordination role, helping align Federal-State radiation protection efforts through meetings, training/education activities, and committee-driven identification and resolution of radiation health and protection issues, under FDA's electronic product radiation control authority.Apply for RFA FD 23 018
- The Department of Health and Human Services, Food and Drug Administration in the consumer protection, health sector is offering a public funding opportunity titled "Assuring Radiation Protection (U18) Clinical Trial Not Allowed" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
- This funding opportunity was created on Nov 29, 2022.
- Applicants must submit their applications by Feb 14, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $105,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: Assuring Radiation Protection (U18) - Clinical Trial Not Allowed (RFA-FD-23-018)
What is the Assuring Radiation Protection (U18) funding opportunity (RFA-FD-23-018)?
It is a discretionary cooperative agreement funded by the U.S. Food and Drug Administration (FDA) within the Department of Health and Human Services. The opportunity supports consumer protection and public health by strengthening radiation safety efforts, especially where FDA has responsibilities related to electronic products that emit radiation.
Which agency is offering and funding this award?
The award is offered and funded by the U.S. Food and Drug Administration (FDA), within the Department of Health and Human Services.
What is the primary purpose of this award?
The purpose is to support coordinated Federal and State efforts that help ensure the American public is protected from radiation-related risks, particularly in areas tied to FDA's responsibilities for radiation-emitting electronic products.
What type of funding mechanism is used (U18), and what does that imply?
This opportunity uses a cooperative agreement mechanism (U18). A cooperative agreement generally means FDA expects substantial involvement in the funded activities, such as ongoing collaboration, coordination, and shared planning between the recipient and FDA to achieve program goals.
Is this opportunity open for clinical trials or clinical research?
No. The notice specifies "Clinical Trial Not Allowed," meaning the project is not intended to support clinical research or clinical trial activity. The funded work should focus on coordination, education, committee-based problem solving, and programmatic support related to radiation protection.
Is this a new award competition or a renewal-focused announcement?
It is renewal-focused. FDA is signaling that it intends to accept and evaluate a renewal application rather than broadly competing multiple brand-new awards.
How much funding is available?
Approximately $105,000 total is available for fiscal year 2023.
What is the award ceiling?
The award ceiling is $105,000.
How many awards does FDA expect to make?
The expected number of awards is one.
What are the main activities the recipient is expected to carry out?
The main work centers on improving coordination and alignment between Federal and State partners on radiation protection activities. Key activities include planning and facilitating an annual meeting of stakeholders, developing and offering educational activities with practical value, and establishing committees to address radiation health and protection issues through structured, ongoing work.
What is the annual meeting deliverable expected to accomplish?
The annual meeting is intended to bring relevant stakeholders together to discuss current challenges, share approaches, and promote consistent strategies for radiation protection across jurisdictions.
What kind of educational activities are expected under this award?
The recipient is expected to develop and offer educational activities that demonstrate practical, mutually beneficial techniques, procedures, and systems that advance the mission of assuring radiation protection. These educational efforts are intended to be applied and useful, helping participants adopt better methods or improve existing programs.
What is the purpose of the committees mentioned in the opportunity?
The committees are meant to address a wide range of radiation health and protection issues by identifying and evaluating problems, discussing emerging concerns, and proposing solutions. The intent is to provide structured, ongoing forums that can track issues over time and generate actionable recommendations for agencies and partners involved in radiation safety.
How does this opportunity relate to FDA's role with radiation-emitting electronic products?
The opportunity is tied to FDA responsibilities for electronic products that emit radiation. While the award funds coordination and education, it supports systems and collaboration that help manage public health risks associated with radiation-emitting products under FDA's regulatory role.
What is the statutory authority for this program?
The program is authorized under section 532 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ii).
Why is the statutory authority important for understanding this award?
The authority supports FDA's ability to establish and operate an electronic product radiation control program. It provides the legal foundation for FDA's role in overseeing radiation-emitting electronic products and promoting public safety, which is the policy context for the coordination and education activities supported by the award.
Who is eligible to apply?
Eligibility is listed broadly as "Others," with additional clarification referenced in the funding notice's eligibility section.
When was the opportunity created, and what was the original closing date?
The opportunity was created on November 29, 2022, and the original closing date was February 14, 2023.
What kind of work is emphasized, based on the description?
The emphasis is on coordinated planning and collaboration, stakeholder convening, applied education/training, and committee-driven identification and resolution of radiation health and protection issues. The work is positioned as programmatic support and alignment across Federal and State partners rather than research or clinical activities.
What is the overall role of the recipient under this award?
The recipient is expected to serve as a convening and coordination hub that helps align Federal-State radiation protection efforts through meetings, practical educational activities, and committee-based problem solving, in collaboration with FDA under the cooperative agreement structure.
Browse more opportunities from the same category: Consumer Protection, Health
Next opportunity: APEX Accelerator- Option Period for Existing Award Recipients
Previous opportunity: Landmarks of American History and Culture
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA FD 23 018
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 23 018", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.